Your browser doesn't support javascript.
loading
Congenital Heart Disease: An Immunological Perspective.
Singampalli, Kavya L; Jui, Elysa; Shani, Kevin; Ning, Yao; Connell, Jennifer P; Birla, Ravi K; Bollyky, Paul L; Caldarone, Christopher A; Keswani, Sundeep G; Grande-Allen, Kathryn Jane.
Afiliação
  • Singampalli KL; Department of Bioengineering, Rice University, Houston, TX, United States.
  • Jui E; Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, United States.
  • Shani K; Laboratory for Regenerative Tissue Repair, Division of Pediatric Surgery, Department of Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Ning Y; Department of Bioengineering, Rice University, Houston, TX, United States.
  • Connell JP; John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, United States.
  • Birla RK; Laboratory for Regenerative Tissue Repair, Division of Pediatric Surgery, Department of Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Bollyky PL; Department of Bioengineering, Rice University, Houston, TX, United States.
  • Caldarone CA; Laboratory for Regenerative Tissue Repair, Division of Pediatric Surgery, Department of Surgery, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Keswani SG; Division of Congenital Heart Surgery, Departments of Surgery and Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Grande-Allen KJ; Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Front Cardiovasc Med ; 8: 701375, 2021.
Article em En | MEDLINE | ID: mdl-34434978
ABSTRACT
Congenital heart disease (CHD) poses a significant global health and economic burden-despite advances in treating CHD reducing the mortality risk, globally CHD accounts for approximately 300,000 deaths yearly. Children with CHD experience both acute and chronic cardiac complications, and though treatment options have improved, some remain extremely invasive. A challenge in addressing these morbidity and mortality risks is that little is known regarding the cause of many CHDs and current evidence suggests a multifactorial etiology. Some studies implicate an immune contribution to CHD development; however, the role of the immune system is not well-understood. Defining the role of the immune and inflammatory responses in CHD therefore holds promise in elucidating mechanisms underlying these disorders and improving upon current diagnostic and treatment options. In this review, we address the current knowledge coinciding CHDs with immune and inflammatory associations, emphasizing conditions where this understanding would provide clinical benefit, and challenges in studying these mechanisms.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article